Cargando…

Maturation Pathways of Cross-Reactive HIV-1 Neutralizing Antibodies

Several human monoclonal antibodies (hmAbs) and antibody fragments, including the best characterized in terms of structure-function b12 and Fab X5, exhibit relatively potent and broad HIV-1 neutralizing activity. However, the elicitation of b12 or b12-like antibodies in vivo by vaccine immunogens ba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Xiaodong, Chen, Weizao, Feng, Yang, Dimitrov, Dimiter S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2009
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185542/ https://www.ncbi.nlm.nih.gov/pubmed/21994570 http://dx.doi.org/10.3390/v1030802

Ejemplares similares

The Antibody Germline/Maturation Hypothesis, Elicitation of Broadly Neutralizing Antibodies Against HIV-1 and Cord Blood IgM Repertoires
por: Prabakaran, Ponraj, et al.
Publicado: (2014)

Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogens
por: Xiao, Xiaodong, et al.
Publicado: (2009)

Cross-Reactive Human IgM-Derived Monoclonal Antibodies that Bind to HIV-1 Envelope Glycoproteins
por: Chen, Weizao, et al.
Publicado: (2010)

Origin, diversity, and maturation of human antiviral antibodies analyzed by high-throughput sequencing
por: Prabakaran, Ponraj, et al.
Publicado: (2012)

Human monoclonal antibodies as candidate therapeutics against emerging viruses and HIV-1
por: Zhu, Zhongyu, et al.
Publicado: (2013)

Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development
por: Li, Wei, et al.
Publicado: (2017)

454 antibody sequencing - error characterization and correction
por: Prabakaran, Ponraj, et al.
Publicado: (2011)

Antibody Aggregation: Insights from Sequence and Structure
por: Li, Wei, et al.
Publicado: (2016)

Conjugates of Small Molecule Drugs with Antibodies and Other Proteins
por: Feng, Yang, et al.
Publicado: (2014)

Epitope Mapping of M36, a Human Antibody Domain with Potent and Broad HIV-1 Inhibitory Activity
por: Wan, Chao, et al.
Publicado: (2013)

Characterization of germline antibody libraries from human umbilical cord blood and selection of monoclonal antibodies to viral envelope glycoproteins: Implications for mechanisms of immune evasion and design of vaccine immunogens
por: Chen, Weizao, et al.
Publicado: (2012)

Bispecific Engineered Antibody Domains (Nanoantibodies) That Interact Noncompetitively with an HIV-1 Neutralizing Epitope and FcRn
por: Gong, Rui, et al.
Publicado: (2012)

HIV-1 gp41-targeting fusion inhibitory peptides enhance the gp120-targeting protein-mediated inactivation of HIV-1 virions
por: Qi, Qianqian, et al.
Publicado: (2017)

One-domain CD4 Fused to Human Anti-CD16 Antibody Domain Mediates Effective Killing of HIV-1-Infected Cells
por: Li, Wei, et al.
Publicado: (2017)

Human Domain Antibodies to Conserved Epitopes on HER2 Potently Inhibit Growth of HER2-Overexpressing Human Breast Cancer Cells In Vitro
por: Wang, Hongqian, et al.
Publicado: (2019)

Structure of Severe Acute Respiratory Syndrome Coronavirus Receptor-binding Domain Complexed with Neutralizing Antibody
por: Prabakaran, Ponraj, et al.
Publicado: (2006)

Identification of Non-HIV Immunogens That Bind to Germline b12 Predecessors and Prime for Elicitation of Cross-clade Neutralizing HIV-1 Antibodies
por: Yang, Zheng, et al.
Publicado: (2015)

Cross-reactivity of glycan-reactive HIV-1 broadly neutralizing antibodies with parasite glycans
por: Huettner, Isabella, et al.
Publicado: (2022)

Human Monoclonal Antibodies Against HIV and Emerging Viruses
por: Dimitrov, Dimiter S.
Publicado: (2008)

P04-07. Guiding the immune system through complex maturation pathways: a novel multi-immunogen approach for elicitation of broadly neutralizing antibodies
por: Xiao, X, et al.
Publicado: (2009)

Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections
por: Ying, Tianlei, et al.
Publicado: (2015)

Strategies for induction of HIV‐1 envelope‐reactive broadly neutralizing antibodies
por: Williams, Wilton B., et al.
Publicado: (2021)

Antibody-based therapeutics against components of the IGF system
por: Feng, Yang, et al.
Publicado: (2012)

Crystal Structure of the Hendra Virus Attachment G Glycoprotein Bound to a Potent Cross-Reactive Neutralizing Human Monoclonal Antibody
por: Xu, Kai, et al.
Publicado: (2013)

Manipulating the selection forces during affinity maturation to generate cross-reactive HIV antibodies
por: Wang, Shenshen, et al.
Publicado: (2015)

Genome-Wide Association Study on the Development of Cross-Reactive Neutralizing Antibodies in HIV-1 Infected Individuals
por: Euler, Zelda, et al.
Publicado: (2013)

Identification and Characterization of a Broadly Cross-Reactive HIV-1 Human Monoclonal Antibody That Binds to Both gp120 and gp41
por: Zhang, Mei-Yun, et al.
Publicado: (2012)

Protocol for constructing large size human antibody heavy chain variable domain (V(H)) library and selection of SARS-CoV-2 neutralizing antibody domains
por: Chen, Chuan, et al.
Publicado: (2021)

Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies
por: Briney, Bryan, et al.
Publicado: (2016)

Cross-reactive broadly neutralizing antibodies: timing is everything
por: Euler, Zelda, et al.
Publicado: (2012)

Soluble HIV-1 Envelope Immunogens Derived from an Elite Neutralizer Elicit Cross-Reactive V1V2 Antibodies and Low Potency Neutralizing Antibodies
por: Carbonetti, Sara, et al.
Publicado: (2014)

Multiscale affinity maturation simulations to elicit broadly neutralizing antibodies against HIV
por: Conti, Simone, et al.
Publicado: (2022)

Recognition determinants of improved HIV-1 neutralization by a heavy chain matured pediatric antibody
por: Kumar, Sanjeev, et al.
Publicado: (2023)

Recognition determinants of improved HIV-1 neutralization by a heavy chain matured pediatric antibody
por: Kumar, Sanjeev, et al.
Publicado: (2023)

Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1
por: Mikell, Iliyana, et al.
Publicado: (2011)

Antibody Neutralization of HIV-1 Crossing the Blood-Brain Barrier
por: Lorin, Valérie, et al.
Publicado: (2020)

The Effects of Framework Mutations at the Variable Domain Interface on Antibody Affinity Maturation in an HIV-1 Broadly Neutralizing Antibody Lineage
por: Zhou, Jeffrey O., et al.
Publicado: (2020)

A cross-neutralizing antibody between HIV-1 and influenza virus
por: Lee, Chang-Chun D., et al.
Publicado: (2021)

Oligomerization of the SARS-CoV S glycoprotein: dimerization of the N-terminus and trimerization of the ectodomain
por: Xiao, Xiaodong, et al.
Publicado: (2004)

Cross-reactive neutralizing activity in HIV-1 infected injecting drug users
por: Euler, Z, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_38as9duej3otfltv5ge5fl2piu